Literature DB >> 32913506

Long non-coding RNA LINC01116 is overexpressed in lung adenocarcinoma and promotes tumor proliferation and metastasis.

Lizhong Zeng1, Xin Lyu1, Jingyan Yuan1, Wei Wang1, Nannan Zhao1, Boxuan Liu1, Ruiying Sun1, Xia Meng1, Shuanying Yang1.   

Abstract

Long non-coding RNA LINC01116 is involved in the occurrence and progression of a variety of cancers. However, the specific role of LINC01116 in lung adenocarcinoma (LUAD) remains unclear. In this work, we found that LINC01116 was overexpressed in LUAD tissues and cell lines and that increased expression was significantly associated with worse prognoses in patients with LUAD. Univariate and multivariate Cox regression analyses indicated that LINC01116 was an independent risk factor for the prognosis of patients with LUAD. Downregulation of LINC01116 significantly inhibited cell proliferation and migration, promoted cell apoptosis, and prevented cell progression from G1 to S phase. In addition, downregulation of LINC01116 significantly inhibited the epithelial-mesenchymal transition, leading to an increased expression of the epithelial marker E-cadherin and decreased expression of the mesenchymal markers N-cadherin and vimentin. In summary, our results suggest that LINC01116 may act as an oncogene in LUAD and may be a valuable prognostic biomarker for patients with LUAD. AJTR
Copyright © 2020.

Entities:  

Keywords:  EMT; LINC01116; lung adenocarcinoma; prognosis; proliferation

Year:  2020        PMID: 32913506      PMCID: PMC7476163     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  34 in total

Review 1.  Review: Regulation of the cancer epigenome by long non-coding RNAs.

Authors:  Megan E Forrest; Ahmad M Khalil
Journal:  Cancer Lett       Date:  2017-04-09       Impact factor: 8.679

Review 2.  Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.

Authors:  Subash Chandra Gupta; Yashoda Nandan Tripathi
Journal:  Int J Cancer       Date:  2016-12-30       Impact factor: 7.396

Review 3.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

4.  Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer.

Authors:  Laura M Beaver; Rachael Kuintzle; Alex Buchanan; Michelle W Wiley; Sarah T Glasser; Carmen P Wong; Gavin S Johnson; Jeff H Chang; Christiane V Löhr; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho
Journal:  J Nutr Biochem       Date:  2017-01-12       Impact factor: 6.048

5.  Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancer.

Authors:  Nan Jiang; Xiaodan Meng; Hongchao Mi; Yidi Chi; Shenghui Li; Zeyu Jin; Hui Tian; Jinxian He; Weiyu Shen; Haihua Tian; Jinchang Pan; Shuai Fang; Xiaofeng Jin; Chengwei Zhou; Zhaohui Gong
Journal:  Clin Chim Acta       Date:  2018-07-17       Impact factor: 3.786

6.  lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway.

Authors:  G-H Wei; X Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-10       Impact factor: 3.507

7.  LncRNA LINC01116 Promotes Cancer Cell Proliferation, Migration And Invasion In Gastric Cancer By Positively Interacting With lncRNA CASC11.

Authors:  Xiaohui Su; Jianjun Zhang; Xianfeng Luo; Wei Yang; Yanqing Liu; Yang Liu; Zexing Shan
Journal:  Onco Targets Ther       Date:  2019-10-03       Impact factor: 4.147

8.  LINC01116 accelerates nasopharyngeal carcinoma progression based on its enhancement on MYC transcription activity.

Authors:  Haijie Xing; Hongxia Sun; Weiluo Du
Journal:  Cancer Med       Date:  2019-11-08       Impact factor: 4.452

Review 9.  Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer.

Authors:  Yiwen Fang; Melissa J Fullwood
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-02-12       Impact factor: 7.691

View more
  7 in total

1.  Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma.

Authors:  Wei Geng; Zhilei Lv; Jinshuo Fan; Juanjuan Xu; Kaimin Mao; Zhengrong Yin; Wanlu Qing; Yang Jin
Journal:  Front Cell Dev Biol       Date:  2021-03-29

2.  Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma.

Authors:  Lan Mu; Ke Ding; Ranran Tu; Wei Yang
Journal:  J Transl Med       Date:  2021-03-26       Impact factor: 5.531

3.  Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.

Authors:  Zhengrong Yin; Mei Zhou; Tingting Liao; Juanjuan Xu; Jinshuo Fan; Jingjing Deng; Yang Jin
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

4.  Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer.

Authors:  Qiaxuan Li; Lintong Yao; Zenan Lin; Fasheng Li; Daipeng Xie; Congsen Li; Weijie Zhan; Weihuan Lin; Luyu Huang; Shaowei Wu; Haiyu Zhou
Journal:  Front Oncol       Date:  2021-10-20       Impact factor: 6.244

5.  A Five Autophagy-Related Long Non-Coding RNA Prognostic Model for Patients with Lung Adenocarcinoma.

Authors:  Boxuan Liu; Shuanying Yang
Journal:  Int J Gen Med       Date:  2021-10-27

6.  A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma.

Authors:  Zetian Gong; Qifan Li; Jun Li; Jiaheng Xie; Wei Wang
Journal:  Transl Cancer Res       Date:  2022-01       Impact factor: 1.241

7.  Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma.

Authors:  Fang Tong; Lifa Xu; Sheng Xu; Mingming Zhang
Journal:  Front Genet       Date:  2022-08-11       Impact factor: 4.772

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.